A wide variety of toxicological study on bensultap have been conducted to assess its safety.
Bensultap is a relatively low toxic substance, and the toxicological signs of treated animals included ptosis, depression, hyperactivity, tremor, urine stains, soft feces, rough coat, lacrimation, salivation and convulsion in acute toxicity studies.
Bensultap technical might be a weak irritant but no-corrosive substance to the rabbit eye, and it caused no skin irritation. Bensultap technical might be a mild allergen, but its formulated product was not to be a sensitizing agent in guinea pig.
In chronic toxicity and oncogenicity studies, main toxicological findings related to the treatment of bensultap were including depression of body weight, decreased hematocrit and hemoglobin values, increased kidney weight and centrilobular hepatocellular swelling in the high dose groups. No treatment-related neoplastic lesions were observed in rats and mice.
The reproductive performance was not influenced with bensultap in rats, and no teratogenic potential was observed in rat and rabbit studies. Bensultap did not indicate a mutagenic potential in any assay.
Bensultap and its formulation were registered on April 14, 1986 in Japan.
The withhold standards for pesticide registration are listed below.
Rice 0.2ppm
Wheat and others 0.2ppm
Vegetables 3.0ppm
Tea 20.0ppm
View full abstract